RenBio is a privately-held, preclinical biotechnology company developing a DNA-based platform technology for delivering antibody and protein therapeutics.
Research Engineer (Electrical) opening at RenBio!
Innovate & become a part of developing an electroporation-based platform technology for next-gen treatments for blood disorders & inflammatory, infectious, and metabolic diseases. Apply here! https://t.co/ZNxYxIEroR
#NYC#biotech
Delighted to announce RenBio has received new Awards to Support Continued Development of our Novel, DNA-Based MYO Technology™ Platform for Antiviral Applications #grants#BARDA#Wellcome Read more:
https://t.co/MPAK36Zd7a
Join our #RenBio team
Seeking a highly motivated & goal-oriented Research Associate to be part of developing nucleic acid-based platform technology for next-gen treatments for blood disorders, inflammatory, & infectious diseases.
https://t.co/YLduEqkNoy
#biotech#jobopening#NYC
Thrilled to announce our participation in the upcoming Life Sciences Summit at the Alexandria Center for Life Science on October 11th.
Join us in Suite 203 at 1:45pm, where our very own @rliberatore will be presenting.
#LifeSciences#AlexandriaSummit#Biotech#Science#NYCBio
In ep.413 of #AIinAction, @rliberatore, President and Chief Scientific Officer at @RenBioNYC discusses their work withinn #BioTech, the role of #data and new #technology & their work with DARPA's #Pandemic Prevention Platform
🎧Listen now 🔽🔽🔽
https://t.co/65j3ScZ2G0
Join @rliberatore, President and Chief Scientific Officer at @RenBioNYC on the next episode of #AIinAction as she tells us all about their work within #biotechnology & more
Full episode drops Jan 20th so stay tuned to https://t.co/U1GseenVWc or wherever you get your #podcasts
(1/4) Career news: after an incredible 7 years, I have decided 2 step down from my position as COO & CDO of @RenBioNYC. Launching & growing RenBio has been one of the most rewarding experiences of my career, & now that it’s established & on a clear development path forward, ...
Join our #RenBio team
Seeking a highly motivated & goal-oriented Research Associate to be part of developing nucleic acid-based platform technology for next-gen treatments for oncology, inflammatory, and infectious disease.
https://t.co/CLfWSO8xu4
#biotech#jobopening#NYC
Always a good day when someone brings treats to @RenBioNYC. Even better when 2 different people bring them on the same day! Thanks Annelyn and @DrMitchSitnick!
Looking forward to tomorrow's episode of #VirtualBreakfast Series featuring @NealPadte
We'll explore his journey with the Aaron Diamond AIDS Research Center at @Columbia, to a founding position at @RenBioNYC
Register here and join us Tomorrow at 9:00!
https://t.co/6iKdPMB4UH
Thank you @DavidCFortier, Lee Golodny, @ZRGPartners & @demycolton for inviting me to participate in a lively panel discussion at #BioFuture2022. It was an honor to be in the company of such insightful contributions and perspectives from my fellow panelists.
Thanks @BioWorld for featuring @RenBioNYC in your News to Notes section yesterday! We're excited to use this new funding to advance our MYO Technology DNA therapeutics platform and bring more medicines to more patients faster. #nycbiotech
https://t.co/H2nIkJEVyA
Super excited to be working with Neal and Rachel and the entire amazing team at @RenBioNYC. Exciting times ahead for rapid delivery of therapeutics to stop infectious disease outbreaks.
Excited to announce that we have been awarded 2 new grants from @DARPA@VanderbiltU & @EmpireStateDev for development of our platform to fight infectious disease outbreaks. #nycbiotech https://t.co/FJCz8GIrrO
We are here at 4th World Congress on Electroporation in Copenhagen. If you are here as well don’t forget to be at Session P31 where Andrew Cameron will be talking about our MYO Technology. #WCE2022
BREAKING NEWS:
The 2022 #NobelPrize in Physiology or Medicine has been awarded to Svante Pääbo “for his discoveries concerning the genomes of extinct hominins and human evolution.”
Looking forward to connecting with colleagues old and new at the @newyorkbio annual meeting, and my first time at Cure at Deerfield Management. What an amazing venue at which to connect with the biotech community, right in the heart of New York City! #nycbiotech
Opening our doors in NYC in 2016, I can attest to this! Diversity:“If we r going 2 tackle...disparities of health, we need 2 think about all communities, & all communities r represented here...” Entrepreneurial spirit:“We...do whatever it takes 2 get it done...that’s New York."🏙